Skip to main content
TipRanks
Go Ultimate75% OFF

Pascal Biosciences Inc (8DZ) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Pascal Biosciences Inc has a market cap or net worth of EUR 504.14K. The enterprise value is EUR 1.32M.

Market Cap
EUR 504.14K
Enterprise Value
EUR 1.32M

Share Statistics

Pascal Biosciences Inc has 39,662,727 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
39,662,727
Owned by Insiders
4.76%
Owned by Institutions
―

Financial Efficiency

Pascal Biosciences Inc’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -23.94%.

Return on Equity (ROE)
-0.28
Return on Assets (ROA)
-0.16
Return on Invested Capital (ROIC)
-23.94%
Return on Capital Employed (ROCE)
-0.30
Revenue Per Employee
847.83K
Profits Per Employee
-137.54K
Employee Count
2
Asset Turnover
0.99
Inventory Turnover
5.81

Valuation Ratios

The current PE Ratio of Pascal Biosciences Inc is -3.05. Pascal Biosciences Inc’s PEG ratio is -0.10.

PE Ratio
-3.05
PS Ratio
0.57
PB Ratio
0.83
Price to FCF
8.51
Price to Operating Cash Flow
8.51
PEG Ratio
-0.10

Income Statement

In the last 12 months, Pascal Biosciences Inc had revenue of 1.70M and earned -275.07K in profits. Earnings per share was -0.01.

Revenue
1.70M
Gross Profit
396.31K
Operating Income
-290.45K
Pretax Income
-275.07K
Net Income
-275.07K
EBITDA
-32.66K
Earnings Per Share (EPS)
-0.01

Cash Flow

In the last 12 months, operating cash flow was 93.88K and capital expenditures 3, giving a free cash flow of 93.88K billion.

Operating Cash Flow
93.88K
Free Cash Flow
93.88K
Free Cash Flow per Share
0.00

Dividends & Yields

Pascal Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
11.75%
Earnings Yield
-38.98%

Stock Price Statistics

Beta
-3.68
52-Week Price Change
-8.33%
50-Day Moving Average
0.01
200-Day Moving Average
0.02
Relative Strength Index (RSI)
―
Average Volume (3m)
―

Important Dates

Pascal Biosciences Inc upcoming earnings date is Mar 25, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 16, 2026
Next Earnings Date
Mar 25, 2027
Ex-Dividend Date
―

Financial Position

Pascal Biosciences Inc as a current ratio of 0.75, with Debt / Equity ratio of 25.20%

Current Ratio
0.75
Quick Ratio
0.45
Debt to Market Cap
0.12
Net Debt to EBITDA
-4.35
Interest Coverage Ratio
-5.38

Taxes

In the past 12 months, Pascal Biosciences Inc has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Pascal Biosciences Inc EV to EBITDA ratio is -9.17, with an EV/FCF ratio of 12.42.

EV to Sales
0.83
EV to EBITDA
-9.17
EV to Free Cash Flow
12.42
EV to Operating Cash Flow
12.42

Balance Sheet

Pascal Biosciences Inc has EUR 60.85K in cash and marketable securities with EUR 394.63K in debt, giving a net cash position of -EUR 333.79K billion.

Cash & Marketable Securities
EUR 60.85K
Total Debt
EUR 394.63K
Net Cash
-EUR 333.79K
Net Cash Per Share
-EUR 0.01
Tangible Book Value Per Share
EUR 0.00

Margins

Gross margin is 29.40%, with operating margin of -23.79%, and net profit margin of -22.13%.

Gross Margin
29.40%
Operating Margin
-23.79%
Pretax Margin
-22.13%
Net Profit Margin
-22.13%
EBITDA Margin
-9.04%
EBIT Margin
-24.03%

Analyst Forecast

The average price target for Pascal Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
3.31%
EPS Growth Forecast
31.75%